Thus, these results suggested that the cell cycle arrest and apoptosis caused by DSD treatment resulted from simultaneous inhibition of Akt/Erk/p53 signaling pathways in GC cells, underscoring the “multi-active component, multi-drug target, and multi-function” characteristics of DSD. This evidence concerns the gene TP53 and disorder of sexual differentiation.